Watch Ticker

Immuron Limited American Depositary Shares

Go to Immuron Limited American Depositary Shares Website

$1.69

0.01 (0.60%)

Live

Previous Close

$1.68

Day Range

$1.66 - $1.71

Previous Day Range

$1.6401 - $1.7

Market Cap

$9.5 million USD

Day Vol.

8845

Previous Day Vol.

37633

Currency

USD

Primary Exchange

Nasdaq

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Flavio Palumbo (Chief Commercial Officer) - Immuron - FY25 global sales exceed projection, up 49% on prior year

Immuron Limited reported record annual sales of AUD$7.3 million for FY25, representing a 49% growth. The company saw strong performance in Australia and North America, with Travelan® sales increasing across both markets.

Related tickers: IMRN.

Read Full Article

N/A - Immuron Letter to Shareholders: Projects Update

Immuron, an Australian biopharmaceutical company, is on track to exceed A$7 million in sales this financial year, a significant increase from the previous year's sales of A$4.9 million. The company also provided updates on its clinical trials for Travelan, IMM-529, and IMM-986, as well as its plans to launch ProIBS in Australia.

Related tickers: IMRN.

Read Full Article

Trending Tickers

Please sign in to view